Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Journal of the American Association for Laboratory Animal Science : JAALAS
|
February 15, 2026
Cuprizone in Peanut Butter: An Alternative Method of Cuprizone Administration to Model Demyelination of the Central Nervous System
Brooke Hawker, Ethan Chiddicks, Jack Flanagan, et al.
Hippocampus
|
December 8, 2011
Secreted amyloid precursor proteins promote proliferation and glial differentiation of adult hippocampal neural progenitor cells
Sara Baratchi, Jane Evans, Warren P Tate, et al.
Plos One
|
May 10, 2019
Clozapine administration enhanced functional recovery after cuprizone demyelination
Nikki Templeton, Bronwyn Kivell, Amy McCaughey-Chapman, et al.
Frontiers in Cellular Neuroscience
|
February 16, 2023
Reprogramming of adult human dermal fibroblasts to induced dorsal forebrain precursor cells maintains aging signatures
Amy McCaughey-Chapman, Marta Tarczyluk-Wells, Catharina Combrinck, et al.
Biomedical Materials (Bristol, England)
|
June 2, 2022
Development of agarose-gelatin bioinks for extrusion-based bioprinting and cell encapsulation
Anusha Dravid, Amy McCaughey-Chapman, Brad Raos, et al.
Stem Cell Research & Therapy
|
November 23, 2024
Reprogrammed human lateral ganglionic eminence precursors generate striatal neurons and restore motor function in a rat model of Huntington's disease
Amy McCaughey-Chapman, Anne Lieke Burgers, Catharina Combrinck, et al.
Cancer Chemotherapy and Pharmacology
|
January 31, 2014
Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma
Raymond Yung, Vahid Seyfoddin, Christopher Guise, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 4, 2004
AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease
Adrian P Kells, Dahna M Fong, Mike Dragunow, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 14, 2017
Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
Laura K Green, Pirooz Zareie, Nikki Templeton, et al.
Scientific Reports
|
February 4, 2021
Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors
Katharina Robichon, Sven Sondhauss, T William Jordan, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Journal of the American Association for Laboratory Animal Science : JAALAS
|
February 15, 2026
Cuprizone in Peanut Butter: An Alternative Method of Cuprizone Administration to Model Demyelination of the Central Nervous System
Brooke Hawker, Ethan Chiddicks, Jack Flanagan, et al.
Hippocampus
|
December 8, 2011
Secreted amyloid precursor proteins promote proliferation and glial differentiation of adult hippocampal neural progenitor cells
Sara Baratchi, Jane Evans, Warren P Tate, et al.
Plos One
|
May 10, 2019
Clozapine administration enhanced functional recovery after cuprizone demyelination
Nikki Templeton, Bronwyn Kivell, Amy McCaughey-Chapman, et al.
Frontiers in Cellular Neuroscience
|
February 16, 2023
Reprogramming of adult human dermal fibroblasts to induced dorsal forebrain precursor cells maintains aging signatures
Amy McCaughey-Chapman, Marta Tarczyluk-Wells, Catharina Combrinck, et al.
Biomedical Materials (Bristol, England)
|
June 2, 2022
Development of agarose-gelatin bioinks for extrusion-based bioprinting and cell encapsulation
Anusha Dravid, Amy McCaughey-Chapman, Brad Raos, et al.
Stem Cell Research & Therapy
|
November 23, 2024
Reprogrammed human lateral ganglionic eminence precursors generate striatal neurons and restore motor function in a rat model of Huntington's disease
Amy McCaughey-Chapman, Anne Lieke Burgers, Catharina Combrinck, et al.
Cancer Chemotherapy and Pharmacology
|
January 31, 2014
Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma
Raymond Yung, Vahid Seyfoddin, Christopher Guise, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 4, 2004
AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease
Adrian P Kells, Dahna M Fong, Mike Dragunow, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 14, 2017
Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
Laura K Green, Pirooz Zareie, Nikki Templeton, et al.
Scientific Reports
|
February 4, 2021
Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors
Katharina Robichon, Sven Sondhauss, T William Jordan, et al.
Page
of 7